Beyond Compliance: How Strategic Risk Analysis Drives Value Creation in Medical Device Development

Risk analysis isn’t a checkbox — it’s a competitive moat. Companies that master ISO 14971’s layered approach (Hazard Analysis → DFMEA → PFMEA → UFMEA) prevent recalls, accelerate approvals, and build patient trust. Here’s how.